Risk of venous thromboembolism for ovarian cancer patients during first-line therapy after implementation of an Enhanced Recovery After Surgery (ERAS) protocol

CONCLUSION: With implementation of an ERAS protocol, only 1 in 46 patients experienced a VTE within 30 days after surgery. However, overall VTE occurred in 1 in 16 patients during first-line therapy. Strategies to further reduce VTE risk, especially during neoadjuvant chemotherapy and surveillance, should be investigated.PMID:34092412 | DOI:10.1016/j.ygyno.2021.05.032

Source: Gynecologic Oncology - June 7, 2021 Category: Cancer & Oncology Authors: Sue Li Alexandra S Bercow Michele Falzone Rajeshwari Kalyanaraman Michael J Worley Colleen M Feltmate Andrea Pelletier Kevin M Elias Source Type: research